Investigation of the cellular and soluble markers of inflammation for the assessment of cardiovascular risk in patients with acute coronary syndrome in Bangladesh
by Talita Zahin Choudhury; Mohammad Kamruzzaman; Laila N. Islam
International Journal of Electronic Healthcare (IJEH), Vol. 11, No. 1, 2019

Abstract: Acute coronary syndrome (ACS), one of the leading causes of mortality in Bangladesh, occurs when a plaque in the coronary artery suddenly ruptures and obstructs the flow of blood to the heart causing myocardial tissue necrosis. In this study, a total of 140 participants were enrolled including 70 ACS patients and 70 non-ACS controls. The total and differential WBC counts, myeloperoxidase (MPO) activity, ischemia-modified albumin (IMA), interleukin-6 (IL-6) and complement functions were investigated and the values were compared between the study groups. We found the total WBC count, neutrophil to lymphocyte ratio (NLR), plasma MPO activity, serum IMA, and IL-6 levels were significantly higher in the ACS patients while the complement-mediated bactericidal activity was significantly lower. The results on NLR, MPO activity, and IL-6 levels demonstrate activation of cellular and soluble inflammatory mediators in ACS, which may be potential diagnostic biomarkers.

Online publication date: Mon, 20-Jul-2020

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Electronic Healthcare (IJEH):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?


Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com